Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DAB2 |
| Upstream (Parents) |
|---|
| (<<) CRYAB → DAB2 |
| (<<) FUT1 → DAB2 |
| (<<) GPNMB → DAB2 |
| (<<) ILK → DAB2 |
| (<<) KCNK1 → DAB2 |
| (<<) LPXN → DAB2 |
| (<<) SCG5 → DAB2 |
| (<<) TIMP3 → DAB2 |
| (<<) VAV3 → DAB2 |
| (<<) VIM → DAB2 |
| Downstream (Children) |
|---|
| DAB2 → ALK (>>) |
| DAB2 → GRPEL1 (>>) |
| DAB2 → KLF2 (>>) |
| DAB2 → MAP2K4 (>>) |
| DAB2 → NUPR1 (>>) |
| DAB2 → PKIG (>>) |
| DAB2 → PLA2G4A (>>) |
| DAB2 → PLEKHF1 (>>) |
| DAB2 → PRNP (>>) |
| DAB2 → PTAFR (>>) |
| DAB2 → RAB5C (>>) |
| DAB2 → RHOQ (>>) |
| DAB2 → THBS1 (>>) |
| DAB2 → UST (>>) |
